Peripheral Angioplasty Market Segmentation
Peripheral Angioplasty Market Product Outlook (USD Billion, 2018-2032)
Peripheral Angioplasty Market End User Outlook (USD Billion, 2018-2032)
Peripheral Angioplasty Market Market Regional Outlook (USD Billion, 2018-2032)
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT
6.1. Overview
6.2. Balloon Catheters
6.3. Stents
6.4. Guidewires
7. PERIPHERAL ANGIOPLASTY MARKET,BY END USER
7.1. Overview
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Cardiac Catheterization Centers
8. PERIPHERAL ANGIOPLASTY MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Peripheral Angioplasty Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Peripheral Angioplasty Market,
9.7. Key developments and Growth Strategies
9.7.1. New ProductLaunch/Service Deployment
9.7.2. Merger &Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income,2022
9.8.2. Major Players R&D Expenditure.2022
10. COMPANY PROFILES
10.1. Boston Scientific Corporation;
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Medtronic;
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Abbott Laboratories;
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Terumo Corporation;
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Johnson & Johnson;
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Cook Medical;
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. B. Braun Melsungen AG;
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Edwards Lifesciences Corporation;
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Becton;
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Dickinson and Company;
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. MicroPort Scientific Corporation;
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Teleflex Incorporated;
10.12.1. Company Overview
10.12.2. Financial Overview
10.12.3. Products Offered
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. W. L. Gore & Associates;
10.13.1. Company Overview
10.13.2. Financial Overview
10.13.3. Products Offered
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
10.14. Biotronik SE & Co. KG;
10.14.1. Company Overview
10.14.2. Financial Overview
10.14.3. Products Offered
10.14.4. Key Developments
10.14.5. SWOT Analysis
10.14.6. Key Strategies
10.15. AngioDynamics, Inc.;
10.15.1. Company Overview
10.15.2. Financial Overview
10.15.3. Products Offered
10.15.4. Key Developments
10.15.5. SWOT Analysis
10.15.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 PERIPHERAL ANGIOPLASTY MARKET, SYNOPSIS, 2018-2032
TABLE 2 PERIPHERAL ANGIOPLASTY MARKET, ESTIMATES &FORECAST, 2018-2032(USD BILLION)
TABLE 3 PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 4 PERIPHERAL ANGIOPLASTY MARKET,BY END USER, 2018-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: PERIPHERAL ANGIOPLASTY MARKET,BY END USER, 2018-2032 (USD BILLION)
TABLE 7 US: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 8 US: PERIPHERAL ANGIOPLASTY MARKET,BY END USER, 2018-2032 (USD BILLION)
TABLE 9 CANADA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 10 CANADA: PERIPHERAL ANGIOPLASTY MARKET,BY END USER, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 3 GERMANY: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT,2018-2032 (USD BILLION)
TABLE 4 GERMANY: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 5 FRANCE: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 7 ITALY: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 8 ITALY: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 9 SPAIN: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 10 SPAIN: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 11 UK: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 12 UK: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 17 JAPAN: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 18 JAPAN: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 19 CHINA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 20 CHINA: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 21 INDIA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 22 INDIA: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 23 AUSTRALIA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 24 AUSTRALIA: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 33 AFRICA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 34 AFRICA: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: PERIPHERAL ANGIOPLASTY MARKET,BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: PERIPHERAL ANGIOPLASTY MARKET, BY END USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE PERIPHERAL ANGIOPLASTY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE PERIPHERAL ANGIOPLASTY MARKET
FIGURE 4 PERIPHERAL ANGIOPLASTY MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 5 PERIPHERAL ANGIOPLASTY MARKET, SHARE (%), BY END USER, 2022
FIGURE 6 PERIPHERAL ANGIOPLASTY MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA: PERIPHERAL ANGIOPLASTY MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 EUROPE: PERIPHERAL ANGIOPLASTY MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 ASIA-PACIFIC: PERIPHERAL ANGIOPLASTY MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 REST OF THE WORLD: PERIPHERAL ANGIOPLASTY MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 PERIPHERAL ANGIOPLASTY MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 12 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 14 MEDTRONIC:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 MEDTRONIC:SWOT ANALYSIS
FIGURE 16 ABBOTT LABORATORIES:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 ABBOTT LABORATORIES:SWOT ANALYSIS
FIGURE 18 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 TERUMO CORPORATION:SWOT ANALYSIS
FIGURE 20 JOHNSON & JOHNSON:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 JOHNSON & JOHNSON:SWOT ANALYSIS
FIGURE 22 COOK MEDICAL:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 COOK MEDICAL:SWOT ANALYSIS
FIGURE 24 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
FIGURE 26 EDWARDS LIFESCIENCES CORPORATION:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 EDWARDS LIFESCIENCES CORPORATION:SWOT ANALYSIS
FIGURE 28 BECTON:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 BECTON:SWOT ANALYSIS
FIGURE 30 DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 DICKINSON AND COMPANY:SWOT ANALYSIS
FIGURE 32 MICROPORT SCIENTIFIC CORPORATION:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 MICROPORT SCIENTIFIC CORPORATION:SWOT ANALYSIS
FIGURE 34 TELEFLEX INCORPORATED:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 TELEFLEX INCORPORATED:SWOT ANALYSIS
FIGURE 36 W. L. GORE & ASSOCIATES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 W. L. GORE & ASSOCIATES:SWOT ANALYSIS
FIGURE 38 BIOTRONIK SE & CO. KG:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 BIOTRONIK SE & CO. KG:SWOT ANALYSIS
FIGURE 40 ANGIODYNAMICS, INC.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 ANGIODYNAMICS, INC.:SWOT ANALYSIS
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
